Rhumbline Advisers Kempharm, Inc Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Kempharm, Inc stock. As of the latest transaction made, Rhumbline Advisers holds 56,874 shares of KMPH stock, worth $280,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,874
Previous 48,255
17.86%
Holding current value
$280,957
Previous $238,000
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KMPH
# of Institutions
101Shares Held
16.2MCall Options Held
220KPut Options Held
38.5K-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.42MShares$12 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$9.06 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.16MShares$5.74 Million3.06% of portfolio
-
Woodline Partners LP San Francisco, CA1.15MShares$5.67 Million0.06% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...